Quantumzyme Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Quantumzyme General Information

Description

Operator of a biotransformation company focused on clean and green chemistry, designed to enhance the functionality of proteins through optimized amino acid sequence prediction. The company's platform offers integrated computational chemistry and bioinformatics tools combined with proprietary algorithms, enabling biotech and pharmaceutical researchers to improve enzyme performance and accelerate protein design workflows.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 53 Umbria
  • Irvine, CA 92618
  • United States
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 53 Umbria
  • Irvine, CA 92618
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quantumzyme Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Jul-2026 Completed Generating Revenue
5. Later Stage VC 31-Jul-2025 Completed Generating Revenue
4. Accelerator/Incubator 01-Apr-2024 Completed Generating Revenue
3. Accelerator/Incubator Completed Pre-Clinical Trials
2. Seed Round 01-Jan-2017 Completed Pre-Clinical Trials
1. Angel (individual) 21-Sep-2016 Completed Pre-Clinical Trials
To view Quantumzyme’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Quantumzyme Patents

Quantumzyme Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023012819-A1 Recombinant transaminase polypeptides Inactive 31-Jul-2021

Quantumzyme Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quantumzyme Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
IKP EDEN Accelerator/Incubator Minority
Manipal-GOK Bioincubator Accelerator/Incubator
The Agarwal Family Corporation Minority
Startup Karnataka Accelerator/Incubator
To view Quantumzyme’s complete investors history, request access »

Quantumzyme FAQs

  • When was Quantumzyme founded?

    Quantumzyme was founded in 2016.

  • Where is Quantumzyme headquartered?

    Quantumzyme is headquartered in Irvine, CA.

  • What is the size of Quantumzyme?

    Quantumzyme has 12 total employees.

  • What industry is Quantumzyme in?

    Quantumzyme’s primary industry is Biotechnology.

  • Is Quantumzyme a private or public company?

    Quantumzyme is a Private company.

  • What is Quantumzyme’s current revenue?

    The current revenue for Quantumzyme is .

  • Who are Quantumzyme’s investors?

    IKP EDEN, Manipal-GOK Bioincubator, The Agarwal Family, and Startup Karnataka have invested in Quantumzyme.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process